Vedolizumab (anti-α4β7-integrin)

Catalog No.A2045 Synonyms: Entyvio

For research use only.
Not for use in humans.

Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.

Vedolizumab (anti-α4β7-integrin)

Purity & Quality Control

Choose Selective Integrin Inhibitors

Biological Activity

Description Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.

Protocol (from reference)

Product Details

CAS No. 943609-66-3
Molecular Weight 145.7 KD
Formulation PBS Buffer, PH 7.4
Isotype Human IgG1
Application Vedolizumab (anti-α4β7-integrin)
Storage Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Sterility 0.2 μM filtered

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vedolizumab (anti-α4β7-integrin) | Vedolizumab (anti-α4β7-integrin) supplier | purchase Vedolizumab (anti-α4β7-integrin) | Vedolizumab (anti-α4β7-integrin) cost | Vedolizumab (anti-α4β7-integrin) manufacturer | order Vedolizumab (anti-α4β7-integrin) | Vedolizumab (anti-α4β7-integrin) distributor